Macrogenics (MGNX) FCF Margin (2012 - 2026)

Macrogenics' (MGNX) quarterly FCF Margin came in at 173.7% in Q1 2026, up 18441.0% year-on-year from N/an in Q1 2025, and down 266.64% on a QoQ basis from 104.24% in Q4 2025.

Macrogenics (MGNX) FCF Margin (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has 15 years of FCF Margin data on file, last reported at 173.7% in Q1 2026.

  • On a quarterly basis, FCF Margin rose 18441.0% year-over-year to 173.7% in Q1 2026; TTM through Mar 2026 was 44.52%, a 249.0% decrease from a year earlier, with the FY2025 full-year figure at 54.24%, down 618.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 173.7%, down from 104.24% in the prior quarter.
  • Over the last five years, FCF Margin for MGNX reached as high as 104.24% in Q4 2025 and fell as low as 532.48% in Q1 2022.
  • Historically, FCF Margin has averaged 177.72% across 5 years, with a median of 173.7% in 2026.
  • Across the five-year window, FCF Margin surged 47937 bps in 2023 and tumbled 45090 bps in 2024, its largest moves.
  • Year by year, FCF Margin stood at 39.57% in 2022, then slumped by 746 bps to 255.58% in 2023, then surged by 62 bps to 97.57% in 2024, then surged by 207 bps to 104.24% in 2025, then tumbled by 267 bps to 173.7% in 2026.
  • Per Business Quant data, the three most recent FCF Margin figures were 173.7% in Q1 2026, 104.24% in Q4 2025, and 41.41% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Macrogenics 254.43 Mn 187.92 Mn - -173.70%

Historic Data

Download Data
DateValue
Mar 31, 2026 -173.70%
Dec 31, 2025 104.24%
Sep 30, 2025 -41.41%
Jun 30, 2025 -209.82%
Mar 31, 2025 -358.12%
Dec 31, 2024 -97.57%
Sep 30, 2024 51.59%
Jun 30, 2024 -410.10%
Mar 31, 2024 -504.01%
Dec 31, 2023 -255.58%
Sep 30, 2023 -343.80%
Jun 30, 2023 -19.47%
Mar 31, 2023 -53.11%
Dec 31, 2022 39.57%
Sep 30, 2022 -24.50%
Jun 30, 2022 -192.92%
Mar 31, 2022 -532.48%
Dec 31, 2021 -386.99%
Sep 30, 2021 -77.71%
Jun 30, 2021 -155.27%